![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 18340-18345, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of We have previously shown that a minimized
insulin receptor (IR) consisting of the first 468 amino acids of the
insulin receptor fused to 16 amino acids from the C terminus of the
Functional Reconstitution of Insulin Receptor Binding Site from
Non-binding Receptor Fragments*
,
Protein Expression and
§ Insulin Research, Novo Nordisk A/S,
2880 Bagsvaerd, Denmark
-subunit (CT domain) bound insulin with nanomolar affinity
(Kristensen, C., Wiberg, F. C., Schäffer, L., and Andersen,
A. S. (1998) J. Biol. Chem. 273, 17780-17786).
In the present study, we show that a smaller construct that has the
first 308 residues fused to the CT domain also binds insulin. Insulin
receptor fragments consisting of the first 468 or 308 residues did not
bind insulin. However, when these fragments were mixed with a synthetic
peptide corresponding to the CT domain, insulin binding was detectable.
At concentrations of 10 µM CT peptide, insulin binding
was fully reconstituted yielding apparent affinities of 9-11
nM. To further investigate the minimum requirement
for the length of the N terminus of IR, we tested smaller
receptor fragments for insulin binding in the presence of the CT
peptide and found that a fragment consisting of the first 255 amino
acids of IR was able to fully reconstitute the insulin binding site,
yielding an apparent affinity of 11 ± 4 nM for insulin.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
L. Gauguin, C. Delaine, C. L. Alvino, K. A. McNeil, J. C. Wallace, B. E. Forbes, and P. De Meyts Alanine Scanning of a Putative Receptor Binding Surface of Insulin-like Growth Factor-I J. Biol. Chem., July 25, 2008; 283(30): 20821 - 20829. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lou, T. P. J. Garrett, N. M. McKern, P. A. Hoyne, V. C. Epa, J. D. Bentley, G. O. Lovrecz, L. J. Cosgrove, M. J. Frenkel, and C. W. Ward The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity PNAS, August 15, 2006; 103(33): 12429 - 12434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Denley, E. R. Bonython, G. W. Booker, L. J. Cosgrove, B. E. Forbes, C. W. Ward, and J. C. Wallace Structural Determinants for High-Affinity Binding of Insulin-Like Growth Factor II to Insulin Receptor (IR)-A, the Exon 11 Minus Isoform of the IR Mol. Endocrinol., October 1, 2004; 18(10): 2502 - 2512. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. George, A. Johansen, M. A. Soos, H. Mortensen, S. Gammeltoft, V. Saudek, K. Siddle, L. Hansen, and S. O'Rahilly Deletion of V335 from the L2 Domain of the Insulin Receptor Results in a Conformationally Abnormal Receptor That Is Unable to Bind Insulin and Causes Donohue's Syndrome in a Human Subject Endocrinology, February 1, 2003; 144(2): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Whittaker, H. Sorensen, V. L. Gadsboll, and J. Hinrichsen Comparison of the Functional Insulin Binding Epitopes of the A and B Isoforms of the Insulin Receptor J. Biol. Chem., November 27, 2002; 277(49): 47380 - 47384. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |